Prabalini Rajendram Selected Research

Prabalini Rajendram Research Topics

6	Neoplasms (Cancer) 01/2023 - 05/2015
6	COVID-19 08/2021 - 01/2020
5	Respiratory Insufficiency (Respiratory Failure) 06/2021 - 10/2015
4	Critical Illness (Critically Ill) 01/2022 - 07/2017
3	Infections 08/2022 - 10/2020
3	Cytokine Release Syndrome 01/2022 - 10/2020
2	Death (Near-Death Experience) 01/2023 - 10/2015
2	Coinfection 08/2022 - 01/2021
2	Inflammation (Inflammations) 08/2021 - 10/2020
2	Pneumonia (Pneumonitis) 06/2021 - 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Heart Arrest (Cardiac Arrest) 01/2023
1	cell-associated neurotoxicity 01/2022
1	Cardiotoxicity 01/2021
1	Bacterial Infections (Bacterial Infection) 11/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2020
1	Disease Progression 11/2020
1	Brain Edema (Cerebral Edema) 01/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020
1	Sepsis (Septicemia) 10/2015
1	Hemorrhage 05/2015
1	Septic Shock (Toxic Shock Syndrome) 10/2013

4	Chimeric Antigen ReceptorsIBA 01/2023 - 11/2020
4	C-Reactive ProteinIBA 08/2021 - 10/2020
3	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2022 - 10/2013
3	Monoclonal AntibodiesIBA 08/2021 - 01/2020
2	CytokinesIBA 01/2023 - 01/2020
2	Immune Checkpoint InhibitorsIBA 10/2021 - 01/2021
2	TroponinIBA 08/2021 - 10/2020
2	canakinumab FDA Link 08/2021 - 10/2020
2	mavrilimumabIBA 06/2021 - 01/2020
2	Granulocyte-Macrophage Colony-Stimulating Factor Receptors (GM-CSF Receptor)IBA 06/2021 - 01/2020
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 06/2021 - 01/2020
2	tocilizumab (atlizumab)FDA Link 01/2021 - 11/2020
2	Interleukin-6 (Interleukin 6)IBA 11/2020 - 10/2020
1	AntigensIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	axicabtagene ciloleucelIBA 01/2022
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 11/2020
1	lenzilumabIBA 01/2020
1	plonmarlimabIBA 01/2020
1	gimsilumabIBA 01/2020

5	Therapeutics 01/2022 - 10/2015
4	Artificial Respiration (Mechanical Ventilation) 01/2021 - 10/2015
2	Resuscitation 01/2023 - 01/2020
1	Cardiopulmonary Resuscitation (CPR) 01/2023
1	Catheters 08/2022
1	Length of Stay 08/2022
1	Immunotherapy 01/2021
1	Mechanical Ventilators (Ventilator) 11/2020
1	Intranasal Administration 01/2020
1	Critical Care (Surgical Intensive Care) 07/2017
1	Physical Therapy Modalities (Physical Therapy Technique) 07/2017
1	Early Ambulation 07/2017
1	Palliative Care (Palliative Therapy) 10/2015
1	Drug Therapy (Chemotherapy) 05/2015